SB 838 Summary

• Requires all health insurers in Hawaii, excluding Medicaid managed care programs, to cover continuous glucose monitors (CGMs) and related supplies for individuals diagnosed with diabetes, including gestational diabetes, regardless of insulin use, effective for policies issued or renewed after December 31, 2025

• CGM coverage must include costs for necessary repairs or replacement parts and be subject to a minimum benefit provision, with copayments, deductibles, and coinsurance no less favorable than other covered medical services

• Defines continuous glucose monitor as a device with a small electronic sensor applied to the skin that measures glucose levels in real-time for a minimum of seven days

• Permits the Department of Health to accept gifts, grants, and donations from individuals, organizations, or government agencies to support expanded CGM access

• Takes effect July 1, 2050; however, insurance coverage requirements apply to all policies issued or renewed after December 31, 2025